DE69121920T2 - Antagonisten reizübertragender aminosäuren - Google Patents

Antagonisten reizübertragender aminosäuren

Info

Publication number
DE69121920T2
DE69121920T2 DE69121920T DE69121920T DE69121920T2 DE 69121920 T2 DE69121920 T2 DE 69121920T2 DE 69121920 T DE69121920 T DE 69121920T DE 69121920 T DE69121920 T DE 69121920T DE 69121920 T2 DE69121920 T2 DE 69121920T2
Authority
DE
Germany
Prior art keywords
irritrating
antagonists
amino acids
isomer
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69121920T
Other languages
English (en)
Other versions
DE69121920D1 (de
Inventor
Greg Hamilton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Corp of North America
Original Assignee
Guilford Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guilford Pharmaceuticals Inc filed Critical Guilford Pharmaceuticals Inc
Publication of DE69121920D1 publication Critical patent/DE69121920D1/de
Application granted granted Critical
Publication of DE69121920T2 publication Critical patent/DE69121920T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/383Cycloaliphatic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4018Esters of cycloaliphatic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503Five-membered rings
    • C07F9/6506Five-membered rings having the nitrogen atoms in positions 1 and 3

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69121920T 1990-12-07 1991-12-04 Antagonisten reizübertragender aminosäuren Expired - Fee Related DE69121920T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62416890A 1990-12-07 1990-12-07
PCT/US1991/008834 WO1992010099A1 (en) 1990-12-07 1991-12-04 Excitatory amino acid antagonists

Publications (2)

Publication Number Publication Date
DE69121920D1 DE69121920D1 (de) 1996-10-10
DE69121920T2 true DE69121920T2 (de) 1997-04-03

Family

ID=24500939

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69121920T Expired - Fee Related DE69121920T2 (de) 1990-12-07 1991-12-04 Antagonisten reizübertragender aminosäuren

Country Status (11)

Country Link
EP (1) EP0639197B1 (de)
JP (1) JP2721933B2 (de)
AT (1) ATE142220T1 (de)
CA (1) CA2097910A1 (de)
DE (1) DE69121920T2 (de)
DK (1) DK0639197T3 (de)
ES (1) ES2094338T3 (de)
GR (1) GR3021881T3 (de)
IE (1) IE75735B1 (de)
WO (1) WO1992010099A1 (de)
ZA (1) ZA919196B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6028213A (en) 1998-04-16 2000-02-22 Eastman Chemical Company Optically active cis-1,3-cyclohexanedicarboxylic acid monoesters with high enantiomeric purity and process for their preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761405A (en) * 1987-03-04 1988-08-02 Nova Pharmaceutical Corporation Antagonists of specific excitatory amino acid neurotransmitter receptors having increased potency

Also Published As

Publication number Publication date
DE69121920D1 (de) 1996-10-10
EP0639197A1 (de) 1995-02-22
CA2097910A1 (en) 1992-06-08
ATE142220T1 (de) 1996-09-15
IE914256A1 (en) 1992-06-17
DK0639197T3 (de) 1997-02-24
ZA919196B (en) 1992-09-30
JP2721933B2 (ja) 1998-03-04
ES2094338T3 (es) 1997-01-16
EP0639197A4 (de) 1994-02-21
WO1992010099A1 (en) 1992-06-25
IE75735B1 (en) 1997-09-24
GR3021881T3 (en) 1997-03-31
JPH06505966A (ja) 1994-07-07
EP0639197B1 (de) 1996-09-04

Similar Documents

Publication Publication Date Title
EA199700260A1 (ru) Готовая препаративная форма 2-метилтиенобензодиазепина для перорального введения и способ ее получения
ES2064665T3 (es) Mejoras en y en relacion con antagonistas de angiotensina ii.
YU104690A (sh) Supstituisani imidazo-kondenzovani 6-člani heterocikli kao antagonisti angiotenzina 2
DE122006000012I1 (de) Lhrh antagonistische Peptide
DE69021618D1 (de) Antagonisten von exzitatorischen Aminosäuren.
MX19448A (es) Procedimiento para la prreparacion de compuestos antagonistas de los receptores de aminoacidos excitadores; compuestos obtenidos y composicion farmaceutica que los incluye.
PT776324E (pt) Antagonista da endotelina
FI945704A0 (fi) Eksitatorisen aminohapporeseptorin antagonisteja
FI950485A0 (fi) Imidatsolikarboksyylihappojen prodrugmuotoja angiotensiini II-reseptorin antagonisteina
NO930035L (no) Eksitatoriske aminosyreantagonister
FI902416A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten aminohappoantagonistien valmistamiseksi
FI940834A (fi) Eksitatoristen aminohapponeurotransmittereiden antagonisteina käyttökelpoisia synteettisiä heteroaryylipolyamiineja
DE69121920T2 (de) Antagonisten reizübertragender aminosäuren
AR004601A1 (es) Antagonistas de receptor de aminoacidos
DK0556152T3 (da) Pyridiniumderivater og deres anvendelse til bestemmelse af bindevævssygdomme hos mennesker og dyr
DK0552712T3 (da) 8-(1-aminocycloalkyl)1,3-dialkylxanthinderivater som antagonister for adenosinreceptorer
FI890678A0 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi
NO931679D0 (no) Nye heterocykliske forbindelser som antagonister for eksitatoriske aminosyrereseptorer, fremgangsmaater for deres fremstilling og deres anvendelse
FI97388B (fi) Menetelmä heterosyklisten NMDA-antagonistien valmistamiseksi
DK0790994T3 (da) Heterocyclisk substituerede propensyrederivater som NMDA-antagonister
TR199801735A2 (xx) 2-(arilfenil)amino-imidazolin türevleri.
NO940604L (no) Syntetiske heteroaryl-polyaminer som antagonister for eksitatoriske aminosyre-neurotransmittere
RU93046495A (ru) Гетероциклические соединения, промежуточные соединения, способ получения и фармацевтическая композиция

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee